Pharmafile Logo
Pharmafocus logo
Advanced Search

Cure.Bio Portfolio Company

Showing 1 posts of 1 posts found.

handshake_2

Secarna Pharmaceuticals and Curie.Bio portfolio company enter research and option agreement

May 14, 2025
Research and Development Corporate, Cure.Bio Portfolio Company, Pharmacy, Secarna Pharmaceuticals, agreement

Global biopharma company, Secarna Pharmaceuticals, and biotech investor, Cure.Bio, have announced signing a research and option agreement, intending to accelerate …

News
The Gateway to Local Adoption Series

Latest content

Europa Biosite enters Czech market with acquisition of diagnostics distributor

November 12, 2026

Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials

November 11, 2026

START and Rome cancer institute partner to expand early-phase trial access in Italy

November 10, 2026

AbbVie expands Oxford R&D facility with new £120m UK research commitment

November 9, 2026

MedPharm appoints Jason Mieding as chief operating officer

November 8, 2026